Wang et al. (2023) found that Bavachin (20, 30, and 40 μmol·L−1 for 24h, 48 h) increased the phosphorylation level of p38/ERK/JNK in a dose-dependent manner, and upregulated the expression of Gadd45a, cleaved PARP and cleaved Caspase-3, inducing apoptosis and inhibiting tumor growth in HT29 and HCT 116 cells. This evidence concerns the gene MAPK14 and neoplasm.